Perceptions and preferences for long-acting injectable and implantable medications in comparison to short-acting medications for opioid use disorders.

•About half of participants preferred short- to long-acting formulations of MOUD.•Mixed evaluations of long- and short-acting formulations focused on medication-related beliefs, burden and practices•Results suggest support for expanded access to a variety of formulations of MOUD